RE: Design freeze2 Jun 2020 22:31
I really think this is mainly about logging and collection of data now and then what the result means. What's the benefit in selling millions of tests for people to get a result without collection of that data? The data is way more valuable than the investment in the test, remember this is not just about commercialising a product this is about providing a solution to beat a pandemic. The specification of the product has to extend to the feedback loop via results and data capture IMO.
To collect the data firstly you need a system. Which sounds like an app, from what CK has said and looking at the switch from Abingdon and BBI from to talking about tracking apps. We know the NHS app is delayed and sounds like not good enough. Look at the solutions Abingdon offer and how this can take the test and trace to a world leading solution that BJ talked about.
Secondly you need an incentive to get people to log the results. Data protection no doubt problematic so they need to find a way to incentive's people to log results.
Finally what does a result mean if its negative or positive? The further relaxation of lockdown measures take away a lot of the problems which could me those with antibodies are granted additional privileges. The government have always said antibodies are the key to unlock the country.
Antibody tests are ongoing. It may well be many more have immunity than we think. But it is heading towards the herd immunity approach in stealth, which means slowly growing natural immunity until a vaccine can accelerate this.
So for me, design freeze is:
A test that is 100% accurate
Integrated logging system, app or website
Information and packaging messaging
You cannot offer the product up for distribution until above is all achieved otherwise the whole point of developing the tests in the first place is circumvented. Every test result leads to a knock on reaction, they are not investing in these just so we can take them ourselves for our own piece of mind and keep the result to ourselves.